On Sunday, December 13, Genomic Health researchers presented results of a large retrospective case-control study assessing the diagnosis of HER2 status, by both fluorescent in situ hybridization (FISH) testing and quantitative RT-PCR by Oncotype DX, to explore the association between polysomy 17 (extra copies of chromosome 17, a condition found in breast cancer patients that can complicate the interpretation of HER2 testing results), HER2 status and breast cancer death.    From Wordnik.com.  [Marketwire - Breaking News Releases] Reference

No amplification or polysomy of the.    From Wordnik.com.  [Naturejobs - All Jobs] Reference